PPARA and breast cancer: In breast cancer stem cells, the PPARα antagonist GW6471 has anti-proliferation and pro-apoptotic effects while the PPARα agonist Wy14643 promotes clonal expansion through NF-κB/IL-6 axis signaling activity promotion (118, 119).